cleaning alone rarely leads to a plaque-free environment 3, 4 and therefore mouthrinses have been used more recently as vehicles for plaque inhibitory agents directed at improving plaque control and or gingival health (for review see references 5 -7) . A wide variety of mouthrinse products are freely available 'over the counter' to the consumer today and figures would indicate that they are commonly used in the home, with the sale of mouthrinses in the UK in 1999 reaching £73 million.
Among the available mouthrinses, chlorhexidine formulations remain undisputed as the gold standard among anti-plaque mouthrinses, 8, 9 but local side effects have tended to restrict their use to the short to medium term. The most significant local side effect of chlorhexidine is the well known formation of extrinsic dental staining of teeth, oral mucosa, restorative materials and acrylic dentures. 10, 11 Other readily available mouthrinses are perhaps less well known for their undesirable staining capabilities. For example, cetylpyridinium chloride (CPC), which is perhaps the most common ingredient in over-the-counter products, can produce dental staining 12, 13 although the degree of staining formed has been noted to be considerably less than that of chlorhexidine. 14 In addition staining by essential oil mouthrinses has been noted. 15 The effect of stain removal by the mechanical action of brushing when mouthrinses are used as adjuncts to brushing may be one explanation for the apparently infrequently noted clinical staining caused by these other rinses.
Several mechanisms have been proposed for the aetiology of extrinsic dental staining associated with cationic antiseptics and some polyvalent metal salts (for review see reference 16). However, both laboratory and clinical evidence strongly support a dietary aetiology whereby staining is caused by the precipitation of dietary chromogens by cationic antiseptics such as chlorhexidine and CPC. [16] [17] [18] [19] [20] This phenomenon has been exploited in vitro to assess the availability of cationic antiseptics in commercially available mouthrinse formulations. [21] [22] [23] Indeed, the method has been employed to predict plaque inhibitory properties of mouthrinses containing cationic antiseptics. 22, [24] [25] [26] [27] [28] • This study highlights the fact that some commercially available mouthrinses may not achieve the plaque inhibitory activity that they are expected to have.
• Ingredients contained within some cationic antiseptic mouthrinse solutions may inactivate the plaque inhibitory agent.
• The study confirms the varying ability of different mouthrinses to form stains in the laboratory and this has been found in many previous studies to be indicative of clinical staining and plaque inhibitory efficacy.
I N B R I E F
The aim of this study was to compare the in vitro staining capability and hence the availability of CPC and chlorhexidine in various brands of commercially available mouthrinse solutions. It was then hoped that the results would allow the possible prediction of in vivo activity among products containing the same antiseptic to be made.
MATERIALS AND METHODS
The method involved cationic antiseptic enhanced tea staining of optically clear methyl methacrylate specimens (Perspex. Amari Plastics plc., Weybridge, Surrey). Rectangular specimens measuring 30 x 10 x 5 mm were prepared to fit the specimen chamber of a UV/visible spectrophotometer. Six specimens were used per experimental group and for logistical purposes it was necessary to run two separate studies under identical laboratory conditions. Specimens were baselined at the lambda maximum for tea namely 295 nm on a UV/visible double beam spectrophotometer. Specimens were then soaked in human saliva for 2 minutes, washed in distilled water and immersed for 2 minutes in a 10 ml solution of each of the 14 chosen mouthrinse solutions (see Table 1 ). A 0.2% chlorhexidine rinse and distilled water were used in both experiments to act as positive and negative standards respectively for each experiment. This would allow observational comparisons to be made between the two experiments on products containing CPC.
Following exposure to the different solutions, specimens were removed, washed in distilled water, and exposed to a 10 ml standard tea solution for 1 hour. The standard tea solution was prepared by using 1 g of tea leaves per 100 ml of boiled tap water. The solution was left to stand for 3 minutes, strained through gauze and left to cool to room temperature. At the end of 1 hour, specimens were removed, washed in distilled water and left to dry before reading on the spectrophotometer. This process was then repeated until the average optical density reading of six blocks of one or more groups at that cycle reached a value of > 2.0.
STATISTICAL METHODS
In this method, to compare activity, comparisons can only be made between the negative standard water and products with the same ingredients, ie CPC or chlorhexidine. Dentyl pH had a noticeable effect on the property of the specimen surfaces and although staining was seen, the optical density readings were considered to be invalid. For the first study, in order to avoid multiple comparisons, one-way analysis of variances were performed on the CPC containing rinses (excluding Dentyl pH for reasons mentioned above) with and without water. If statistically significant differences were found, the pre-study plan was to perform an unpaired t test between the least staining CPC rinse and water and the next least staining CPC rinse at the 5% level of significance. Alpha errors were minimised by using a Bonferroni correction. Thus, statistical analysis was only performed between Boots Total Care and water as no significant differences were found between the five CPC rinses without water. For the second study involving six CPC rinses and water the planned statistical analysis was as for study 1. For the chlorhexidine rinses again analysis of variances were performed between the three rinses with and without water, if significant, it was planned to compare the lowest staining rinse with water and the next least staining chlorhexidine rinse using unpaired t tests with a Bonferroni correction.
RESULTS
In both studies a total of six staining cycles were required before an average optical density of > 2.0 was produced, and this was in the 0.2% chlorhexidine groups (positive control). The results for each group at cycle 6 can be seen in Figures 1 and 2 . In both experiments, 0.2% chlorhexidine rinse stained the most and to a 
DISCUSSION
The use of optically clear acrylic specimens to assess and measure in vitro staining has been used on many occasions in previous studies. 18, [29] [30] [31] This study involved the pre-treatment of such specimens with saliva as this is known to significantly increase in vitro staining. 32 The optical density of stain produced on the specimens throughout progressive cycles was used to assess the availability of cationic antiseptics within several mouthrinse solutions. A total of twelve CPC rinses were examined. A concentration of 0.05% CPC was stipulated in only two of these formulations. However, this is the most common concentration known to be incorporated in commercial formulations and CPC has been found to be most effective in plaque re-growth studies at concentrations of between 0.05% and 0.1% (for review see reference 6). This study complemented the findings of other studies in the following respects. Firstly, in a study comparing in vitro staining by various CPC rinses, 21 a Sainsbury's formulation performed exceptionally well. In the same study, a UK formulation containing 0.1% chlorhexidine was found to produce a comparable, if not greater amount of mean staining than a 0.2% chlorhexidine rinse, a finding which is not altogether surprising since the optimal concentration for chlorhexidine staining in vitro is known to peak at 0.1%. 32 Secondly, staining by chlorhexidine and several of the CPC containing rinses was essentially similar. CPC has been shown to adsorb to acrylic to a greater extent than chlorhexidine, 18,31 but the overall increased staining seen in the positive control groups using 0.2% chlorhexidine may be explained by the dicationic nature of chlorhexidine which may account for this difference once the antiseptic has been adsorbed.
The absence of dental staining in short term non-brushing clinical trials involving cationic antiseptics has been shown to be reflected in a lack of plaque inhibitory activity. 26, 33 This can be said either to be caused by the failure to comply with rinsing regimens on the part of the patient, or due to the active ingredient incorporated in the mouthrinse not being available. Indeed, research has confirmed that the mere incorporation of an active ingredient in a formulation does not necessarily imply clinical efficacy. 24, 27 Other studies in vitro and in vivo have consistently demonstrated that attempts to block staining by chlorhexidine and CPC result in a loss of plaque inhibitory activity. 22, 24 Although laboratory data clearly cannot stand alone, cautious extrapolation of activity to the clinical situation may be made between products containing the same active ingredient and one particular previous study has managed to position the clinical efficacy, in mean terms, for several chlorhexidine containing mouthrinses in order using in vitro staining data. 24 Applying this knowledge to these in vitro studies, therefore, one may predict that there would be a decreased availability of CPC in several of the mouthrinses used in both experiments, and of a decreased availability of chlorhexidine in the French 0.1% chlorhexidine formulation compared with the UK version, as numerically, staining in this group was little different from water. These findings may in turn imply a decreased clinical efficacy although obviously, clinical studies are undoubtedly required to back up this conclusion. However, a previous clinical study on the French 0.1% chlorhexidine formulation 24 found it to perform poorly both in terms of plaque inhibition and salivary bacterial counts compared with other chlorhexidine rinses. In addition to this, disappointing studies in vitro and in vivo of the original 0.1% chlorhexidine rinse available in the UK at the time 26, 34 led to a formulation change to improve activity. 23 These findings clearly indicate that the manufacturers of the 0.1% chlorhexidine product reformulated in the UK but not in France. Researchers have proposed that the addition of certain ingredients such as detergents into mouthrinses may be responsible for the apparent lack of availability of some cationic antiseptics. For example, it is known very similar level of optical density. The negative standard water produced little staining but the optical density was lower in the second compared with the first study. Across studies therefore it is apparent that there was considerable variation in staining potential of the CPC rinses. Thus two products produced staining at or around an optical density of 0.5, and therefore similar to water, seven products achieved an optical density of around 1.5 to just < 2.0 and three products exceeded an optical density of 2.0. For the chlorhexidine rinses in the second study the 0.2% and UK 0.1% chlorhexidine products achieved an optical density respectively of just greater than and just less than 2.5, but the equivalent French version of 0.1% chlorhexidine achieved an optical density of around 0.5.
In study 1 (Fig. 1) , analysis of variance excepting the data for Dentyl pH showed no significant difference between the other 5 CPC rinse products without water (P = 0.473). However, with water the difference was extremely significant (P < 0.001). The difference between Boots Total Care (the CPC with the lowest optical density of the 5 rinses) and water was found to be highly significant (P < 0.001) with a difference in mean staining at cycle 6 of 59%.
In study 2 ( Fig. 2) , analysis of variance across the six CPC rinse products without water revealed highly significant differences between products (P < 0.001). This difference appeared largely due to Pearl Drops Smokers which achieved the lowest optical density of all the products in this experiment and to a level highly significantly lower than the rinse with the next lowest optical density, namely Scope (P < 0.001) there being 63% more stain formed with Scope. An analysis of variance with water showed highly significant differences across the groups (P < 0.001). Despite the much reduced staining by Pearl Drops Smokers, a 35% increase in staining was seen compared with water which was significantly greater (P = 0.002).
Stain formation amongst the chlorhexidine containing rinses both with and without water in study 2 was found to differ to a highly significant degree (P < 0.001) with the most stain at cycle 6 being formed by the 0.2% product, followed by the UK and finally the French 0.1% chlorhexidine formulations. The UK formulation produced almost four times the amount of stain compared with the French formulation, a difference which was highly significant (P < 0.001). Compared with water, the increase in stain produced by the French formulation was numerically small but highly significant (P < 0.001). that inactivation of cationic antiseptics may occur by anionic compounds such as sodium lauryl sulphate. 35 Interestingly, Pearl Drops Smokers CPC mouthwash contains sodium lauroyl sarcosinate and this may perhaps, therefore, explain its poor staining performance which was only marginally greater than water. Dentyl pH was not included in the statistical analysis of mean group staining as a sticky film was noted to form on the specimens in this group and this may have affected true optical density readings. Manufacturers' guidelines about this product recommend avoiding contact with plastics containing polystyrene, and this may have been the reasoning behind these findings.
In summary, this study has highlighted varying in vitro staining capabilities of commercially available mouthrinse products containing the same active ingredients. Previous research has demonstrated that staining by cationic antiseptics in vitro has correlated well with in vivo staining and plaque inhibitory activity. The study has also predicted a lack of availability of both CPC and chlorhexidine in some of the mouthrinses evaluated in this study in vitro. In conclusion, based on previous studies in vitro and in vivo, these experiments suggest that several CPC and chlorhexidine mouthrinses will not achieve the expected chemical plaque inhibitory benefits for which they were formulated.
